⚗️ biochemistry

The pod components of the Shigella T3SS sorting platform accommodate multiple copies of Spa33 (SctQ)

This study utilizes AlphaFold modeling and mutational analysis to propose a revised architecture for the *Shigella* T3SS sorting platform pod, suggesting that two or potentially four copies of the SctQ protein (Spa33) bind to the adaptor MxiK and SPOA2 homodimers to better fit experimental electron density and explain functional requirements.

Original authors: Whittier, S. K., Tachiyama, S., Heydari, S., Picking, W. L., Liu, J., Picking, W. D.

Published 2026-02-27

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Whittier, S. K., Tachiyama, S., Heydari, S., Picking, W. L., Liu, J., Picking, W. D.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine a bacterium like Shigella is a tiny, high-tech spy. To do its job, it needs to sneak a package of "bad news" (proteins) directly into a human cell. To do this, it uses a microscopic machine called the Type III Secretion System (T3SS). Think of this machine as a molecular syringe or a hypodermic needle that can pierce a cell wall and inject its payload.

This paper is about figuring out exactly how the "engine room" of this syringe is built. Specifically, the scientists were trying to solve a puzzle about a part of the machine called the "sorting platform."

Here is the breakdown of what they found, using simple analogies:

1. The Mystery of the "Pod"

The sorting platform is like the loading dock inside the bacterium. Its job is to grab the right packages (proteins) and load them onto the needle.

The Problem: Scientists knew what the individual parts looked like (like having the blueprints for a car engine), but when they tried to put them together to match the blurry 3D pictures (electron density maps) they took of the whole machine, the pieces didn't fit. It was like trying to build a Lego castle where the instructions were missing, and the pieces kept falling off.
The Key Players:
- MxiK (The Dock Manager): A protein that sits on the membrane (the floor of the loading dock).
- Spa33 (The Forklifts): Proteins that pick up the packages.
- Spa33short (The Helper Forklifts): A smaller version of the forklift that helps the big ones work.

2. The Big Discovery: "Two Forklifts per Manager"

For a long time, scientists thought the Dock Manager (MxiK) only held one Forklift (Spa33). But the math and the blurry pictures didn't add up.

Using a super-smart AI tool called AlphaFold (which is like a digital architect that predicts how proteins fold), the researchers built a new model. They discovered that the Dock Manager actually has two hands. It holds two Forklifts at the same time!

The Analogy: Imagine a bus driver (MxiK). Everyone thought he could only hold one ticket puncher (Spa33). But the new model shows he actually has two ticket punchers clipped to his belt, ready to go. This makes the system much more efficient and stable. If one puncher gets tired and leaves, the other is still there to keep the bus running.

3. Testing the Theory: Breaking the Machine

To prove this wasn't just a computer guess, the scientists played "break it to fix it." They took the bacteria and changed specific letters in the DNA of the Dock Manager and the Forklifts.

The Experiment: They targeted the "glue" spots where these proteins stick together.
The Result: When they changed those specific spots, the bacteria lost their ability to inject anything. The machine broke. This confirmed that the "Two Forklifts per Manager" model is real and essential for the machine to work.

4. The "Ghost" in the Machine

There was still a mystery. Even with the new "Two Forklifts" model, there was still some empty space (ghostly density) in the bottom part of the loading dock in the pictures that the model didn't fill.

The New Hypothesis: The scientists noticed that if you add two more Forklifts (making it four total instead of two), they might fit into that empty space.
The Evidence: When they looked at broken machines (mutants), they saw that the bottom part of the dock was still there, even though the main engine (the ATPase) was missing. This suggests that maybe there are actually four Forklifts in the dock, not just two. This would explain the extra space and matches other studies that suggested there are four copies of this protein.

Why Does This Matter?

Think of the Shigella bacteria as a thief trying to break into a bank (your cells). The "sorting platform" is the thief's tool belt.

If we understand exactly how the tool belt is built, we can design a lockpick (a drug) that jams the belt.
If the belt jams, the thief can't pick the lock, and the infection stops.

Summary

This paper is like solving a 3D jigsaw puzzle where the pieces were invisible.

They used AI to guess the shape of the pieces.
They found that the "Dock Manager" holds two "Forklifts" (not one).
They proved this by breaking the bacteria and seeing it stop working.
They suspect there might actually be four Forklifts total, which explains some leftover empty space in the pictures.

It's a major step forward in understanding how these bacterial machines work, bringing us closer to designing better ways to stop them.

1. Problem Statement

The Type III Secretion System (T3SS) is a critical virulence nanomachine used by Gram-negative pathogens like Shigella flexneri to inject effector proteins into host cells. While the structural details of the membrane-embedded "injectisome" (needle and basal body) are well-characterized, the cytoplasmic sorting platform remains poorly understood at atomic resolution.

The Gap: The sorting platform consists of an adaptor (SctK/MxiK), a "pod" protein (SctQ/Spa33), and spoke proteins (SctL/MxiN) connecting to a central ATPase (SctN/Spa47).
The Conflict: Existing low-resolution cryo-electron tomography (cryo-ET) maps show a large electron density for the pod that cannot be fully explained by a simple 1:1:1 stoichiometry (one MxiK, one Spa33, one MxiN). Fluorescence microscopy suggests a higher stoichiometry (up to 4 copies of SctQ per pod), but no structural model has successfully fit the experimental density while maintaining known molecular interactions.
The Specific Question: How many copies of Spa33 bind to MxiK, and how does the alternatively translated Spa33short (SPOA2 homodimer) integrate into this complex to form a functional sorting platform?

2. Methodology

The authors employed a multi-disciplinary approach combining computational modeling, mutagenesis, functional assays, and structural biology:

Computational Modeling (AlphaFold 3): Used to predict the multimeric structures of the MxiK-Spa33 complex (testing 1:1 and 2:1 stoichiometries) and the interaction between full-length Spa33 and the Spa33short homodimer.
Computational Alanine Scanning: Utilized the BUDE algorithm to identify "hot-spot" residues at the predicted interfaces (MxiK-Spa33 and Spa33-Spa33short) that contribute significantly to binding energy ( $\Delta\Delta G$ ).
Site-Directed Mutagenesis: Created specific point mutations (e.g., F67D, F70D, L46D, F219D/Y221A) in Shigella flexneri strains lacking endogenous spa33 or mxiK.
Functional Assays:
- Contact-mediated Hemolysis: Measured the ability of bacteria to lyse red blood cells (a proxy for T3SS pore formation).
- Congo Red (CR)-induced Secretion: Quantified the secretion of IpaB and IpaD effectors via Western blot.
Cryo-Electron Tomography (cryo-ET):
- Prepared Shigella minicells expressing mutant T3SS components.
- Performed subtomogram averaging to visualize the in-situ structure of mutant injectisomes.
- Refined models by fitting AlphaFold-predicted complexes into experimental cryo-ET density maps using ChimeraX.

3. Key Contributions & Results

A. The 2:1 MxiK:Spa33 Stoichiometry

Prediction: AlphaFold predicted that a single MxiK molecule binds two copies of Spa33 (specifically the N-terminal domain, Spa33N) at two distinct, adjacent hydrophobic patches on MxiK.
Validation: Computational scanning identified hot-spot residues (e.g., F67, F70, L79 on Spa33; L46, F16 on MxiK).
Experimental Confirmation: Mutating these hot-spot residues (e.g., F67D, F70D, L46D) resulted in a near-complete loss of hemolytic activity and effector secretion, confirming that both binding sites on MxiK are essential for T3SS function. This validates the 2:1 stoichiometry over the previously assumed 1:1 model.

B. The Role of Spa33short

Prediction: AlphaFold modeled the full-length Spa33 interacting with the Spa33short homodimer (alternatively translated SPOA2 domains) at the linker region between Spa33N and Spa33C.
Validation: Mutations disrupting the Spa33/Spa33short interface (e.g., F219D/Y221A in Spa33 and E285 in Spa33short) drastically reduced or eliminated T3SS activity.
Conclusion: The Spa33short homodimer is not merely an accessory but a critical structural component required for the stability and function of the pod.

C. Structural Fitting and Model Refinement

The Model: The authors proposed a complex consisting of 1 MxiK : 2 Spa33 : 2 Spa33short.
Density Fitting: When fitted into the cryo-ET map, this model occupied the upper two-thirds of the pod density with a high cross-correlation score (0.74).
Novel Positioning: The model places the protein components closer to the inner membrane than previously depicted in literature. In this orientation:
- The two Spa33N domains occupy the density previously attributed solely to MxiK.
- MxiK and its cytoplasmic domain (MxiGC) share the membrane-proximal density.
- This arrangement explains a "donut hole" in the center of the pod density as the space between the Spa33/Spa33short tetramers.

D. Insights from Mutant Cryo-ET

Observation: Mutants with disrupted interfaces (e.g., spa33 mutants) still retained some pod density but lacked density for the MxiN spokes and the central ATPase (Spa47).
Implication: A stable pod structure (intact MxiK-Spa33-Spa33short interactions) is a prerequisite for recruiting the ATPase and forming the spokes.
Alternative Hypothesis: The unmodeled density in the lower third of the pod (present even in some mutants) suggests an alternative model where four copies of Spa33 exist per pod (replacing the Spa33short dimers with full-length Spa33 C-domains). This would align with fluorescence data suggesting 4 SctQ copies per pod, though the authors note this requires further structural validation.

4. Significance

Resolving the Stoichiometry: The paper provides the first experimentally validated structural model for the Shigella sorting platform pod that accounts for multiple copies of SctQ, resolving the discrepancy between low-resolution density maps and biochemical data.
Mechanistic Insight: It demonstrates that the pod is a dynamic, multi-copy assembly where the presence of a second Spa33 copy likely allows for the rapid exchange of components (cycling) without destabilizing the entire platform.
Therapeutic Potential: By defining the critical interfaces (MxiK-Spa33 and Spa33-Spa33short) required for function, the study identifies specific targets for small-molecule inhibitors that could disrupt T3SS assembly and virulence.
Methodological Advance: It showcases the power of combining AlphaFold multimer prediction with computational alanine scanning and in vivo functional validation to solve complex macromolecular assemblies that are difficult to crystallize.

In summary, this work redefines the architecture of the Shigella T3SS sorting platform, establishing a 2:1 MxiK:Spa33 stoichiometry dependent on the Spa33short homodimer, and provides a high-confidence structural model that fits experimental cryo-ET data while offering a new perspective on the platform's proximity to the inner membrane.